Statera BioPharma (STU:7CB) OCF Margin %: 0.00% (As of Sep. 2022)


What is Statera BioPharma OCF Margin %?

Statera BioPharma STU:7CB 20 OCF Margin % is 0.00% as of Sep. 2022. GuruFocus rates STU:7CB with a GF Score™ of 20/100. The stock has 1 warning sign investors should review.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. Statera BioPharma's Cash Flow from Operations for the three months ended in Sep. 2022 was €-0.81 Mil. Statera BioPharma's Revenue for the three months ended in Sep. 2022 was €0.00 Mil. Therefore, Statera BioPharma's OCF Margin % for the quarter that ended in Sep. 2022 was 0.00%.

As of today, Statera BioPharma's current OCF Yield % is 0.00%.

The historical rank and industry rank for Statera BioPharma's OCF Margin % or its related term are showing as below:


STU:7CB's OCF Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -66.52
* Ranked among companies with meaningful OCF Margin % only.

Statera BioPharma OCF Margin % Related Terms

Statera BioPharma OCF Margin % Historical Data

* Premium members only.

The historical data trend for Statera BioPharma's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Statera BioPharma OCF Margin % Chart

Statera BioPharma Annual Data
Trend Dec19 Dec20 Dec21
OCF Margin %
0.00 0.00 0.00

Statera BioPharma Quarterly Data
Dec19 Mar20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22
OCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Statera BioPharma OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

Statera BioPharma's OCF Margin for the fiscal year that ended in Dec. 2021 is calculated as

OCF Margin=Cash Flow from Operations (A: Dec. 2021 )/Revenue (A: Dec. 2021 )
=-24.951/0
= %

Statera BioPharma's OCF Margin for the quarter that ended in Sep. 2022 is calculated as

OCF Margin=Cash Flow from Operations (Q: Sep. 2022 )/Revenue (Q: Sep. 2022 )
=-0.81/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Margin % →
What does a OCF Margin % of 0.00% mean?
Statera BioPharma (STU:7CB) has a OCF Margin % of 0.00% as of Sep. 2022. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Statera BioPharma and its competitors.
Is Statera BioPharma's OCF Margin % too high?
Statera BioPharma's current OCF Margin % is 0.00%. Overall, Statera BioPharma has a GF Score™ of 20/100, reflecting its overall financial health beyond just this single metric.
How does Statera BioPharma's OCF Margin % compare to NRBO and PALI?
Statera BioPharma's OCF Margin % of 0.00% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Biotechnology company?
A good OCF Margin % depends on the Biotechnology industry context. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Statera BioPharma and its competitors. Statera BioPharma's current OCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Statera BioPharma stock overvalued right now?
Statera BioPharma (STU:7CB) has a current OCF Margin % of 0.00%. The current OCF Margin % is 0.00%. Statera BioPharma's overall GF Score™ is 20/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Statera BioPharma (STU:7CB), the current OCF Margin % is 0.00% as of Sep. 2022. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Statera BioPharma Business Description

Address 2580 East Harmony Road, Suite 316, Fort Collins, CO, USA, 80528
Statera BioPharma Inc is a pre-clinical and clinical biopharmaceutical company developing multiple product candidates to address unmet medical needs for use in diseases involving immune system dysfunction. Its proprietary platform of Toll-like receptor drug candidates has applications in mitigation of radiation injury, mitigation of T-cell exhaustion, inflammation, T-cell exhaustion, immune system dysfunction, oncology, infection and neutropenia.